Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.48 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.48 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.48 |
| ▸ | VNN1 | O95497 | 7/20 | 0.46 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.46 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.46 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.46 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | KMO | O15229 | 2/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17352126 | 1.00 | TAS1R3 (0.48) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 | |
| SCHEMBL78878 | 0.85 | TAS1R3 (0.54) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 | |
| SCHEMBL31438988 | 0.85 | TAS1R3 (0.54) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 | |
| SCHEMBL10659911 | 0.82 | VNN1 (0.56) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 | |
| SCHEMBL18964966 | 0.81 | TAS1R3 (0.48) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 | |
| SCHEMBL17352154 | 0.80 | KDR (0.51) | NOTUM | |
| SCHEMBL17352152 | 0.80 | KDR (0.51) | NOTUM | |
| SCHEMBL759728 | 0.79 | KCNQ3 (0.54) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 | |
| SCHEMBL2577750 | 0.79 | TAS1R3 (0.49) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 | |
| SCHEMBL30641942 | 0.79 | VNN1 (0.54) | TAS1R3TAS1R1TAS1R2VNN1KCNQ3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | claimed |
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | HCN2, SCO2, HCN1 | TAS1R3 2220/4885TAS1R1 1379/4885TAS1R2 1302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.